Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review

References

• The Global Asthma Report 2018. cited 2019 Jun 22. Accessed at http://www.globalasthmareport.org/Global%20Asthma%20Report%202018%20EMBARGOED.pdf
   Google Scholar
• Sears MR. Trends in the prevalence of asthma. Chest. 2014;145(2):219–13.
   PubMed Web of Science ®Google Scholar
• Robinson D, Humbert M, Buhl R, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161–175.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315–323.
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Janson C, Borres M, et al. Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity. J Allergy Clin Immunol. 2016;138(5):1301–8 e2.
   Web of Science ®Google Scholar
• Global Initiative for Asthma. 2019 GINA Report, Global strategy for asthma management and prevention. cited 2019 Jun 22. Accessed at https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf
   Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725.
   PubMed Web of Science ®Google Scholar
• Israel E, Reddel HK, Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377(10):965–976. .
   PubMed Web of Science ®Google Scholar
• Hoyte FCL, Gross LM, Katial RK. Exhaled Nitric Oxide: an Update. Immunol Allergy Clin North Am. 2018;38(4):573–585.
   PubMed Web of Science ®Google Scholar
• Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993;6(9):1368–1370.
   PubMed Web of Science ®Google Scholar
• Lane C, Knight D, Burgess S, et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax. 2004;59(9):757–760.
   Web of Science ®Google Scholar
• Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163–2173.
   PubMed Web of Science ®Google Scholar
• Maniscalco M, Vitale C, Vatrella A, et al. Fractional exhaled nitric oxide-measuring devices: technology update. Med Devices (Auckl). 2016;9:151–160.
   Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615.
   PubMed Web of Science ®Google Scholar
• Schneider A, Wagenpfeil G, Jorres RA, et al. Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma. BMJ Open. 2015;5(11):e009676.
   Web of Science ®Google Scholar
• Nerpin E, Olivieri M, Gislason T, et al. Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Clin Exp Allergy. 2019;49(7):969–979.
   Web of Science ®Google Scholar
• Bjermer L, Alving K, Diamant Z, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med. 2014;108(6):830–841. .
   PubMed Web of Science ®Google Scholar
• Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–1200.
   PubMed Web of Science ®Google Scholar
• Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452–456.
   PubMed Web of Science ®Google Scholar
• Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58(4):322–327.
   PubMed Web of Science ®Google Scholar
• Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol. 2005;116(3):477–486.
   PubMed Web of Science ®Google Scholar
• Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol. 2004;113(1):101–108.
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372(9643):1049–1057. .
   PubMed Web of Science ®Google Scholar
• Salter B, Pray C, Radford K, et al. Regulation of human airway smooth muscle cell migration and relevance to asthma. Respir Res. 2017;18(1):156.
   PubMedGoogle Scholar
• van Rensen EL, Sont JK, Evertse CE, et al. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med. 2005;172(7):837–841. .
   PubMed Web of Science ®Google Scholar
• Ortega H, Yancey SW, Keene ON, et al. Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma. J Allergy Clin Immunol Pract. 2018;6(3):980–6.e1.
   PubMed Web of Science ®Google Scholar
• Coumou H, Westerhof GA, de Nijs SB, et al. Predictors of accelerated decline in lung function in adult-onset asthma. Eur Respir J. 2018;51:2.
   Web of Science ®Google Scholar
• Sood A, Qualls C, Schuyler M, et al. Adult-onset asthma becomes the dominant phenotype among women by age 40 years. the longitudinal CARDIA study. Ann Am Thorac Soc. 2013;10(3):188–197.
   Google Scholar
• Kankaanranta H, Tuomisto LE, Ilmarinen P. Age-specific incidence of new asthma diagnoses in Finland. J Allergy Clin Immunol Pract. 2017;5(1):189–91.e3.
   Web of Science ®Google Scholar
• Matsunaga K, Hirano T, Oka A, et al. Persistently high exhaled nitric oxide and loss of lung function in controlled asthma. Allergol Int. 2016;65(3):266–271.
   Web of Science ®Google Scholar
• van Veen IH, Ten Brinke A, Sterk PJ, van Veen IH, Ten Brinke A, Sterk PJ, Sont JK, Gauw SA, Rabe KF, et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J. 2008;32(2):344–349.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Fujimura M, Tokuda A, et al. Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma. Allergy Asthma Proc. 2009;30(4):419–423.
   PubMed Web of Science ®Google Scholar
• Semprini R, Williams M, Semprini A, et al. Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma. J Allergy Clin Immunol Pract. 2018;6(6):1982–8 e1.
   Web of Science ®Google Scholar
• Petsky HL, Kew KM, Turner C, et al. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016(9):CD011440.
   Google Scholar
• Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61(9):817–827.
   PubMed Web of Science ®Google Scholar
• Pijnenburg MW. The Role of FeNO in Predicting Asthma. Front Pediatr. 2019;7:41.
   PubMed Web of Science ®Google Scholar
• Leung TF, Tang MF, Leung ASY, et al. Trajectory of spirometric and exhaled nitric oxide measurements in Chinese schoolchildren with asthma. Pediatr Allergy Immunol. 2018;29(2):166–173.
   Web of Science ®Google Scholar
• Elliott M, Heltshe SL, Stamey DC, Elliott M, Heltshe SL, Stamey DC, Cochrane ES, Redding GJ, Debley JS. Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers. Clin Exp Allergy. 2013;43(12):1351–1361.
   Web of Science ®Google Scholar
• Kimura H, Konno S, Makita H, et al. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up. Clin Exp Allergy. 2018;48(9):1137–1146.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Ten Brinke A, Sterk PJ, Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, et al. Frequent exacerbators–a distinct phenotype of severe asthma. Clin Exp Allergy. 2014;44(2):212–221.
   PubMed Web of Science ®Google Scholar
• Abdelrahman M, Iesa M, Awooda HA, et al. Fractional exhaled nitric oxide along with a reduced force expiratory volume are conclusive prognostic biomarkers to alert for asthma exacerbation. Sudan Med Monitor. 2017;12(1):1–7.
   Google Scholar
• Mansur AH, Srivastava S, Sahal A. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function. Respir Med. 2018;143:31–38.
   Web of Science ®Google Scholar
• Gelb AF, Flynn Taylor C, Shinar CM, et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006;129(6):1492–1499.
   PubMed Web of Science ®Google Scholar
• Loymans RJ, Honkoop PJ, Termeer EH, et al. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model. Thorax. 2016;71(9):838–846.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Holliday M, Reddel HK, et al. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial. Lancet Respir Med. 2020;8(7):671–680.
   PubMed Web of Science ®Google Scholar
• Visitsunthorn N, Mahawichit N, Maneechotesuwan K. Association between levels of fractional exhaled nitric oxide and asthma exacerbations in Thai children. Respirology. 2017;22(1):71–77.
   Web of Science ®Google Scholar
• Malerba M, Radaeli A, Olivini A, et al. The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study. Curr Pharm Des. 2015;21(32):4752–4762.
   PubMed Web of Science ®Google Scholar
• Expert Panel Report 3 (EPR-3): guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94–138.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Oshikata C, Tsuburai T, et al. Markers for step-down of inhaled corticosteroid therapy in adult asthmatics. Allergol Int. 2012;61(3):419–429.
   PubMed Web of Science ®Google Scholar
• Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164(5):738–743.
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Yanagisawa S, Hirano T, et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy. 2012;42(5):775–781.
   Web of Science ®Google Scholar
• Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J. 2008;31(3):539–546.
   Web of Science ®Google Scholar
• Ozier A, Girodet PO, Bara I. Tunon de Lara JM, Marthan R, Berger P. Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients. Respir Med. 2011;105(7):989–996.
   Web of Science ®Google Scholar
• Yamashita M, Shibanai M, Sekimura K, et al. Fractional exhaled nitric oxide levels as a predictor of long-term prognoses in patients with mild asthma. Respir Investig. 2016;54(3):139–147.
   Web of Science ®Google Scholar
• Tsilogianni Z, Hillas G, Bakakos P, et al. Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clin Exp Allergy. 2016;46(7):923–931.
   PubMed Web of Science ®Google Scholar
• Kilic H, Oguzulgen IK, Bakir F, et al. Asthma in obese women: outcomes and factors involved. J Investig Allergol Clin Immunol. 2011;21(4):290–296.
   PubMed Web of Science ®Google Scholar
• Yang S, Park J, Lee YK, et al. Association of longitudinal fractional exhaled nitric oxide measurements with asthma control in atopic children. Respir Med. 2015;109(5):572–579.
   Web of Science ®Google Scholar
• Kim JK, Jung JY, Kim H, et al. Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma. Respirology. 2017;22(3):466–472.
   Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Zhang F, et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011;128(2):412–414.
   Web of Science ®Google Scholar
• Delgado-Corcoran C, Kissoon N, Murphy SP, et al. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med. 2004;5(1):48–52.
   PubMedGoogle Scholar
• Pijnenburg MW, Hofhuis W, Hop WC, et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax. 2005;60(3):215–218.
   PubMed Web of Science ®Google Scholar
• Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med. 2005;171(10):1077–1082.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Jarque A, Tosca R, et al. Is it necessary to treat all asthmatic children with raised levels of exhaled nitric oxide?: treating the patient or the data. Allergol Immunopathol (Madr). 2011;39(5):280–283.
   Web of Science ®Google Scholar
• Van Vliet D, Smolinska A, Jobsis Q, et al. Association between exhaled inflammatory markers and asthma control in children. J Breath Res. 2016;10(1):016014.
   Web of Science ®Google Scholar
• Eller MCN, Vergani KP, Saraiva-Romanholo BM, et al. Can inflammatory markers in induced sputum be used to detect phenotypes and endotypes of pediatric severe therapy-resistant asthma? Pediatr Pulmonol. 2018;53(9):1208–1217.
   PubMed Web of Science ®Google Scholar
• Visitsunthorn N, Prottasan P, Jirapongsananuruk O, et al. Is fractional exhaled nitric oxide (FeNO) associated with asthma control in children? Asian Pac J Allergy Immunol. 2014;32(3):218–225.
   Web of Science ®Google Scholar